1. Home
  2. FEMY vs VNCE Comparison

FEMY vs VNCE Comparison

Compare FEMY & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • VNCE
  • Stock Information
  • Founded
  • FEMY 2004
  • VNCE 2002
  • Country
  • FEMY United States
  • VNCE United States
  • Employees
  • FEMY N/A
  • VNCE N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • FEMY Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • FEMY Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • FEMY 18.6M
  • VNCE 20.2M
  • IPO Year
  • FEMY 2021
  • VNCE 2013
  • Fundamental
  • Price
  • FEMY $0.38
  • VNCE $1.50
  • Analyst Decision
  • FEMY Strong Buy
  • VNCE Strong Buy
  • Analyst Count
  • FEMY 3
  • VNCE 4
  • Target Price
  • FEMY $7.33
  • VNCE $4.13
  • AVG Volume (30 Days)
  • FEMY 1.6M
  • VNCE 17.0K
  • Earning Date
  • FEMY 08-08-2025
  • VNCE 09-10-2025
  • Dividend Yield
  • FEMY N/A
  • VNCE N/A
  • EPS Growth
  • FEMY N/A
  • VNCE N/A
  • EPS
  • FEMY N/A
  • VNCE N/A
  • Revenue
  • FEMY $1,887,016.00
  • VNCE $292,214,000.00
  • Revenue This Year
  • FEMY $103.55
  • VNCE $1.93
  • Revenue Next Year
  • FEMY $148.13
  • VNCE $4.91
  • P/E Ratio
  • FEMY N/A
  • VNCE N/A
  • Revenue Growth
  • FEMY 98.61
  • VNCE 1.46
  • 52 Week Low
  • FEMY $0.31
  • VNCE $1.02
  • 52 Week High
  • FEMY $1.80
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 24.33
  • VNCE 50.74
  • Support Level
  • FEMY $0.36
  • VNCE $1.39
  • Resistance Level
  • FEMY $0.42
  • VNCE $1.57
  • Average True Range (ATR)
  • FEMY 0.06
  • VNCE 0.07
  • MACD
  • FEMY -0.01
  • VNCE 0.01
  • Stochastic Oscillator
  • FEMY 16.48
  • VNCE 60.26

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: